SCHEMBL20265568

SCHEMBL20265568

O=C(O)Nc1cnc(-c2ncco2)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 9/20 0.47
▸ TRPM4 Q8TD43 1/20 0.39
▸ ADORA2A P29274 2/20 0.38
▸ ADORA2B P29275 2/20 0.38
▸ SORT1 Q99523 2/20 0.36
▸ LRRK2 Q5S007 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PIN1 Q13526 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ FAAH O00519 1/20 0.33
▸ EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23928440 0.88 MALT1 (0.46) MALT1TRPM4ADORA2AADORA2BLRRK2
SCHEMBL20283653 0.81 MALT1 (0.45) MALT1TRPM4
SCHEMBL20278394 0.74 HPGDS (0.33) MALT1ADORA2AADORA2BLRRK2PIN1
SCHEMBL24869524 0.73 MALT1 (0.51) MALT1NPC1ALDH1A1LMNARAB9A
SCHEMBL6386383 0.72 MAOB (0.49) MALT1NPC1ALDH1A1LMNARAB9A
SCHEMBL20265085 0.71 PLAU (0.37) MALT1ADORA2AADORA2BPIN1
SCHEMBL20265550 0.71 PIN1 (0.35) MALT1ADORA2AADORA2BNPC1ALDH1A1
SCHEMBL28723922 0.70 HDAC4 (0.50) TRPM4NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL23928432 0.69 CFTR (0.44) MALT1ADORA2AADORA2BSMN1; SMN2ADORA3
SCHEMBL24869563 0.68 MALT1 (0.32) MALT1PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954214-B2 Pyrazole derivatives as MALT1 inhibitors JANSSEN PHARMACEUTICA NV (BE) 2021-03-23 — — US disclosed
EP-3558969-A1 PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS Janssen Pharmaceutica NV (BE) 2019-10-30 — — EP disclosed
WO-2018119036-A1 PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS JANSSEN BIOTECH, INC. (US) 2018-06-28 — — WO disclosed
US-20180170909-A1 PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS JANSSEN-CILAG (FR) 2018-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954214-B2 Pyrazole derivatives as MALT1 inhibitors MALT1, PPP3R1, SQSTM1 MALT1 1/4885TRPM4 4289/4885ADORA2A 4799/4885
US-20180170909-A1 PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS MALT1, PPP3R1, SQSTM1 MALT1 1/4885TRPM4 4289/4885ADORA2A 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback